There is established an Opioids and STOP Pain Initiative, to be administered by the Director of the National Institutes of Health, in coordination with other agencies, as appropriate, which shall include efforts to support research on the following: (1) Section 108 of the Comprehensive Addiction and Recovery Act of 2016 (42 U.S.C. 284q1), known as the STOP Pain Act, which directs the National Institutes of Health to intensify and coordinate fundamental, translational, and clinical research with respect to (A) the understanding of pain; (B) the discovery and development of therapies for chronic pain; and (C) the development of alternatives to opioids for effective pain treatments. (4) The Federal Pain Research Strategy, including research that focuses on (A) novel drugs, nonaddictive, and non pharmacological treatments for pain; (B) screening tools and outcome measures for assessments across the continuum of pain; (C) national registries, datasets, and research networks; (D) effective models of care delivery for pain management; and (E) precision medicine methodology to prevent and treat pain. This Act may be cited as the Opioids and STOP Pain Initiative Act. The National Institutes of Health, if the payment is made in support of the Opioids and STOP Pain Initiative, as established by the Opioids and STOP Pain Initiative Act. (5) The components of the Department of Health and Human Services fivepoint strategy to address the opioid crisis that states: Providing support for cutting edge research on pain and addiction. Not later than October 1 of each of fiscal years 2019 through 2026, the Director of the National Institutes of Health shall submit to the Committee on Health, Education, Labor, and Pensions and the Committee on Appropriations of the Senate and the Committee on Energy and Commerce and the Committee on Appropriations of the House of Representatives, a report that includes (1) the amount obligated or expended in the fiscal year prior to the fiscal year in which the report is being submitted for each program or activity described in this Act (or an amendment made by this Act); (2) a description of all such programs or activities carried out using funds provided under this Act (or amendments); and (3) a description of how such programs or activities are advancing public health, including the impact on treating pain and addressing opioid misuse in the United States. SECTION 1.